Secretin Infusion for Pain Due to Chronic Pancreatitis
ChiRhoClin, Inc. · Chronic Pancreatitis
Phase 1 / Phase 2
Completed
12
2016-03
Industry sponsor intelligence
ChiRhoClin, Inc.Clinical Pipeline.
Lead-sponsor view of ChiRhoClin, Inc.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 3
- Recruiting
- 0
- Active
- 0
- Completed
- 2
- Results posted
- 2
- Avg enrollment
- 39
Pipeline overview
Programs by phase and activity.
Velocity
ChiRhoClin, Inc. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
4phase labels
Early Phase 10
Phase 11
Phase 22
Phase 31
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Secretin → | 3 | 1 | 2 | 1 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers
ChiRhoClin, Inc. · Pancreatic Disease
Phase 3
Completed
64
2011-12
Search sponsor records
All ChiRhoClin, Inc. studies.
This page groups studies where ChiRhoClin, Inc. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
3 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT03686618Secretin for Acute PancreatitisApr 10, 2019NCT01265875Secretin Infusion for Pain Due to Chronic PancreatitisMar 9, 2016NCT01087801A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA MarkersDec 6, 2011